restricts

May 18 (UPI) — The U.S. Centers for Disease Control and Prevention on Monday restricted non-U.S. passport holders from entering the United States if they have been in Uganda, the Democratic Republic of the Congo or South Sudan in the past 21 days.

The agency made the announcement as there have at least 346 cases and 88 deaths in the DRC, on top of several cases that have been confirmed in nearby nations in people who been there, the CDC said over the weekend.

The CDC said that is coordinating with various agencies and companies to manage travelers who have been exposed to Ebola as it also deploys employees to support containment of the outbreak in the three nations.

“CDC assess the immediate risk to the general U.S. public as low, but we will continue to evaluate the evolving situation and may adjust public health measures as additional information becomes available,” the agency said in a situation summary.

In the last five days, the World Health Organization confirmed that the Ebola virus circulating in the three countries right now is the Bundibuyo virus, one of four known strains that have affected humans since Ebola was discovered in mid-1970s.

Although there is an approved, licensed vaccine against Ebola which has successfully been used to quell outbreaks, the vaccine — called Ervebo — only protects against acquisition of the Zaire species of Ebola virus, making it useless in the current outbreak, according to the CDC.

WHO on Saturday declared the outbreak a public health emergency of international concern.

In its update, WHO said that there are “significant uncertainties to the true number of infected persons and geographic spread associated with this event at the present time. In addition, there is limited understanding of the epidemiologic links with known or suspected cases.”

Ebola spreads from wild animals to humans and from human to human through direct contact with blood or other bodily fluids from infected individuals, and carries a case fatality rate of roughly 50%.

A number of affected Americans have reportedly been exposed to the virus during the outbreak.

The CDC has recommended that people who have traveled through the two countries in the last 21 days should immediately seek medical attention if they develop Ebola symptoms, which can include fever, weakness, vomiting, diarrhea or unexplained bleeding.

In addition to roughly 30 CDC employees dispatched to the region, and will join officials from several other global and regional health agencies, the WHO is expected to convene an emergency committee to advise the agency’s director-general on its response the outbreak.

May 13 (UPI) — The United States announced visa restrictions on 13 people linked to a U.S.-sanctioned, India-based online pharmacy that the Trump administration accuses of selling Americans hundreds of thousands of counterfeit prescription pills laced with fentanyl.

The people targeted by the State Department on Tuesday were identified as being “close business associates of KS International Traders and its owner.”

The U.S. Treasury sanctioned KS International and Mohammad Iqbal Shaikh, 34, in September. Shaikh was also among 19 people indicted in New York in the fall of 2024 on charges of selling counterfeit, fentanyl-laced pills to Americans over the Internet and via encrypted messaging platforms.

The targeting of KS International comes amid the Trump administration’s broader crackdown on drug smuggling. Among tactics employed was President Donald Trump‘s December 2025designation of illicit fentanyl and its core precursor chemicals as weapons of mass destruction.

In June, Secretary of State Marco Rubio announced a new policy to impose visa restrictions on drug traffickers, their family members and close personal and business associates.

State Department spokesperson Thomas Pigott said Tuesday that the barring of entry to the 13 individuals “underscores the United States’ and India’s enduring and shared commitment to dismantling illicit drug entities and disrupting trafficking networks that harm Americans.”

“Those complicit in poisoning Americans will be denied entry to the United States,” he said in a statement.

The Trump administration has increasingly used visa restrictions across several policy areas, from punishing Haitian government officials and members of criminal organizations accused of obstructing the nation’s fight against terrorist gangs to Nicaraguan citizens believed to be facilitating irregular immigration into the United States.

NEW ORLEANS — A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking mailing of mifepristone prescriptions.

Friday’s unanimous ruling from a three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals is requiring that the abortion pill be distributed only in person and at clinics, overruling regulations set by the federal Food and Drug Administration.

The ruling, which is likely to be appealed to the U.S. Supreme Court, is the biggest jolt to abortion policy in the U.S. since the 2022 Supreme Court ruling that overturned Roe vs. Wade and allowed states to enforce abortion bans.

In the ruling, Judge Kyle Duncan, who was appointed by President Trump, agreed with the state of Louisiana’s contention that allowing the drug to be mailed there makes moot the state’s ban on abortion at all stages of pregnancy.

“Every abortion facilitated by FDA’s action cancels Louisiana’s ban on medical abortions and undermines its policy that ‘every unborn child is a human being from the moment of conception and is, therefore, a legal person,’” the ruling states.

Commonplace treatment

Mifepristone was approved in 2000 as a safe and effective way to end early pregnancies. It is typically used in combination with a second drug, misoprostol.

Surveys have found that the majority of abortions in the U.S. are provided via pills and that about 1 in 4 abortions nationally are prescribed via telehealth.

One survey of abortion providers last year estimated that more women in states where abortion is banned obtained abortions that way than by traveling to other states.

Some Democratic-led states have laws that seek to protect providers who prescribe via telehealth to patients in places with bans.

That rise in prominence is why abortion opponents have targeted the pills in legislation and litigation.

Little precedent

There is little precedent for a federal court overruling the scientific regulations of the FDA, and it wasn’t immediately clear how quickly or completely the decision would affect mailing of the drug throughout the country.

Judges have long deferred to the agency’s judgments on the safety and appropriate regulation of drugs.

FDA officials under Trump have repeatedly stated that the agency is conducting a new review of mifepristone’s safety, at the direction of the president.

The judges, all nominated by Republican presidents, noted in their ruling that the FDA “could not say when that review might be complete and admitted it was still collecting data.”

Because of rare cases of excessive bleeding, the FDA initially imposed strict limits on who could prescribe and distribute the pill — only specially certified physicians and only after an in-person appointment where the person would receive the pill.

Both requirements were dropped during the COVID-19 emergency. At the time, FDA officials under President Biden said that after more than 20 years of monitoring mifepristone use, and reviewing dozens of studies involving thousands of women, it was clear that women could safely use the pill without direct supervision.

GenBioPro, which makes generic mifepristone, said in a statement that the court’s decision “ignores the FDA’s rigorous science and decades of safe use of mifepristone in a case pursued by extremist abortion opponents.”

Broader impact

In a court filing, Louisiana’s attorney general and a woman who said she was coerced into taking abortion pills requested that the FDA rules be rolled back to when the pills were allowed to be prescribed and dispensed only in person.

A Louisiana-based federal judge last month ruled that those allowances undermined the state’s abortion ban but stopped short of undoing the regulations immediately.

Friday’s ruling is in effect as the case works its way through the courts and extends beyond Louisiana and other states with abortion bans.

Telehealth prescriptions have become common even in states where abortion is allowed — and the ruling blocks them there, too.

“This is going to affect patients’ access to abortion and miscarriage care in every state in the nation,” said Julia Kaye, an ACLU lawyer. “When telemedicine is restricted, rural communities, people with low incomes, people with disabilities, survivors of intimate partner violence and communities of color suffer the most.”

The National Right to Life Committee said the ruling “restores a critical layer of oversight” in women’s health.

“Women deserve better than an abortion-by-mail system that prioritizes ideology over safety,” said Carol Tobias, the group’s president.

Next step

Friday’s ruling sets up a likely appeal to the Supreme Court.

“I look forward to continuing to defend women and babies as this case continues,” Louisiana Atty. Gen. Liz Murrill, a Republican, said in a statement.

The conservative-majority high court overturned abortion as a nationwide right in 2022 but unanimously preserved access to mifepristone two years later.

That 2024 decision sidestepped the core issues, however, by ruling that the antiabortion doctors behind the case didn’t have legal standing to sue.

Representatives for the FDA and the U.S. Department of Justice did not immediately respond to requests for comment Friday evening.

In the meantime, antiabortion groups are celebrating Friday’s ruling. Marjorie Dannenfelser, president of Susan B. Anthony Pro-Life America, applauded the ruling as “a huge victory for victims and survivors of Biden’s reckless mail-order abortion drug regime.” She also criticized the Trump administration for taking time to conduct its own review of mifepristone, saying its slow movement has forced states to take action.

“Women and children suffer and state sovereignty is violated every day the FDA allows abortion drugs to flood the mail,” Dannenfelser said.

Mulvihill and Schoenbaum write for the Associated Press. AP writers John Hanna, Matthew Perrone and Lindsay Whitehurst contributed to this report.

The State Department in the United States has announced it is restricting visas for “individuals from countries in our hemisphere who support our adversaries in undermining America’s interests in our region”.

Thursday’s statement underlined that 26 individuals had already seen their visas stripped as part of the policy.

The State Department’s stance comes as President Donald Trump seeks to expand US influence across the Western Hemisphere, as part of a platform he calls the “Donroe Doctrine”, a riff on the 19th-century Monroe Doctrine.

Since taking office for a second term, Trump has taken an aggressive stance towards stopping drug trafficking across the Americas, threatening economic penalties and military action for noncompliance.

He has also sought to check China’s growing sway over the region, as an increasing number of Latin American countries tighten their bonds with the Asian superpower.

The State Department explained that the expanded visa restrictions would penalise those who “knowingly direct, authorise, fund, or provide significant support to” US adversaries in the Western Hemisphere.

“Activities include but are not limited to: enabling adversarial powers to acquire or control key assets and strategic resources in our hemisphere; destabilising regional security efforts; undermining American economic interests; and conducting influence operations designed to undermine the sovereignty and stability of nations in our region,” the statement added.

The language was vague, never mentioning China or the campaign against drug-trafficking cartels.

But it continues a trend under the Trump administration to revoke visas from foreign critics and political opponents.

Last year, for instance, the administration sought to revoke visas for pro-Palestine protesters, claiming their presence could have foreign policy consequences for the US.

More recently, the administration has terminated the immigration visas for at least seven individuals with familial ties to the Iranian government or individuals connected to the 1979 Iranian revolution.

Revoking visas

The statement on Thursday did not identify the 26 individuals facing visa restrictions as part of the expanded policy.

But it cited the same authority under the Immigration and Nationality Act that the Trump administration has used to attempt to deport pro-Palestine student protesters last year.

Under the law, the entry of foreign nationals can be restricted when the secretary of state has reason to believe they pose “potentially serious adverse foreign policy consequences for the United States”.

While the administration has abandoned deportation efforts against some of the targeted individuals, at least two, Mahmoud Khalil and Badar Khan Suri, continue to face expulsion.

More recently, the administration has terminated the immigration visas for at least seven individuals with familial ties to the Iranian government or individuals connected to the 1979 Iranian revolution.

Already, some figures in Latin America have seen their visas revoked over political disagreements with the US.

In July, Brazilian officials involved in the prosecution of former right-wing President Jair Bolsonaro saw their US visas withdrawn. They included Brazilian Supreme Court Justice Alexandre de Moraes, a frequent target of right-wing ire.

Then, in September, the Trump administration stripped Colombian President Gustavo Petro of his visa after he made an appearance at the UN General Assembly that was critical of US policy.

The State Department, at the time, denounced Petro for “reckless and incendiary actions”. He was later invited to visit the White House in February, as part of a detente with Trump.

Visa restrictions have been part of Trump’s larger policy to exert pressure on foreign groups and limit immigration into the US.

Earlier this year, the administration enacted immigrant visa bans on dozens of countries, citing both national security and alleged stresses on social services.

Trump has also sought to take a more militaristic approach towards Latin American governments it deems as adversarial, referring to the whole of the Western Hemisphere as the US’s “neighbourhood”.

In January, the US launched an attack on Venezuela that culminated in the abduction and imprisonment of Venezuelan leader Nicolas Maduro, and it has also initiated an ongoing fuel blockade against Cuba.

Some of Trump’s actions in the region have been deadly. The Venezuela attack left dozens of Cubans and Venezuelans killed. And since September, the Trump administration has conducted at least 51 lethal strikes on alleged drug-smuggling boats in the eastern Pacific Ocean and Caribbean Sea.

The death toll in that campaign has reached at least 177 people. Rights groups have decried the attacks as extrajudicial killings.

But the Trump administration has labelled multiple drug cartels as “foreign terrorist organisations” and has argued they are seeking to destabilise the US through the drug trade.